Draft guidance from the FDA on MoCRA: Facility Registration & Product Listing

20,00 excl. VAT



In this 30-minute webinar, our speakers will walk you through the first draft guidance from the FDA on MoCRA, and specifically on the registration and listing of cosmetic facilities and cosmetic products. Our experts break down MoCRA chapter by chapter, offering insights on how to comply with MoCRA by December 29, 2023.


      • FDA released first Guidance on MoCRA: What are the implications for the cosmetic industry?
      • Facility registration: What is a facility and who has to register?
      • Product listing: Which products must be listed and what information is required?


Geoff Waby – Obelis USA Board of Directors

Geoff Waby has more than 35 years of experience in Quality Assurance and Regulatory Affairs covering OTC drugs and cosmetics. He was the quality assurance lead for Procter & Gamble in Europe, the Middle East, and Africa, before holding the same role for Estée Lauder, firstly in Europe, followed by North America. Geoff served on committees with Cosmetics Europe and is an active member of the Personal Care Products Council. He is co-chair of the PCPC Manufacturing Hygiene task force and an adjunct instructor at the James L Winkle College of Pharmacy, University of Cincinnati. Geoff is an expert in the Modernization of Cosmetics Regulations Act of 2022 (MoCRA).

Silvia Zarzuela Martin – Obelis Business Development Department

She is a Junior Consultant in the Business Development Department at Obelis Group. Silvia leverages partnerships with other entities and takes part in a wide variety of projects supporting corporate buildout.


Published on August 23, 2023